ESCMID eLibrary
Search results
Icon explanation
Icon explanation
close
Abstract
ePoster
Handout
Image
Journal Article
Presentation
Video
Webcast
Found 10 results
-
P2778
Proposed cefepime-AAI101 (30/20 ug) and cefepime (30 ug) disk diffusion quality control ranges using a CLSI M23 (2018) multi-laboratory study design
16 April 2019
Session: Disk diffusion sucseptibility testing
Relevance:100% -
P1876
In vitro activity of omadacycline and comparators against Gram-positive and -negative clinical isolates collected in 2018 from patients in European medical centres: SENTRY surveillance program results
15 April 2019
Session: In vitro activity of newer antibacterial agents
Relevance:100% -
P1847
In vitro activity of BWC0977 (a novel bacterial topoisomerase inhibitor) and comparators against recent clinical and molecularly characterized Enterobacteriaceae and non-fermenter isolates from the United States and Europe
15 April 2019
Session: New topoisomerase inhibitors
Relevance:100% -
P1170
In vitro activity of the extended-spectrum beta-lactamase inhibitor AAI101, in combination with cefepime, against 90 molecularly characterized Enterobacteriaceae isolates expressing a variety of non-beta-lactam resistance mechanisms
14 April 2019
Session: New beta-lactamase inhibitors: in vitro studies
Relevance:100% -
O0269
In vitro activity of APX001A and comparator agents against 1706 fungal isolates collected during an international surveillance programme (2017)
13 April 2019
Session: Novel approaches to fungal diseases
Relevance:100% -
P2492
Cefepime-AAI101 and cefepime MIC quality-control ranges using a CLSI M23-A4 multi-laboratory study design
24 April 2018
Session: Various aspects of antimicrobial susceptibility testing
Relevance:100% -
P1822
Activity of omadacycline and comparators against Gram-positive and -negative clinical isolates (including resistant organism subsets) collected in 2017 from patients in European medical centres: SENTRY surveillance programme results
23 April 2018
Session: Resistance in various Gram-positives
Relevance:100% -
P0157
Disk content assessment and proposed breakpoint interpretive criteria for cefepime in combination with AAI101
21 April 2018
Session: Antimicrobial susceptibility testing by disk diffusion
Relevance:100% -
P1253
In vitro activity of omadacycline and comparators against Gram-negative bacterial isolates collected from patients in European medical centres (2016): results from the SENTRY antimicrobial surveillance programme
24 April 2017
Session: New data on new tetracyclines
Relevance:100% -
P1262
In vitro activity of omadacycline and comparators against staphylococci, streptococci and enterococci (including resistant organism subsets) from patients in European medical centres during 2016: results from the SENTRY antimicrobial surveillance progr
24 April 2017
Session: New data on new tetracyclines
Relevance:100%
Search narrowed by
-
Topics
-
Type of material
-
Time period
